Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Fung

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Hepatology International|June 18, 2021
The clinical and economic burden of non-alcoholic steatohepatitis in the Middle East: behind the sceneLung-Yi Mak, James Fung
Alimentary Pharmacology & Therapeutics|August 10, 2023
Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation-Insights from a real-world studyLung-Yi Mak, James Fung
Hepatology International|April 19, 2020
Proton pump inhibitors in chronic liver disease: accomplice or bystander?Lung-Yi Mak, James Fung
The Indian Journal of Medical Research|August 21, 2023
World Hepatitis Day 2023: Are we close to the target?Rex Wan-Hin Hui, James Fung
Journal of Gastroenterology and Hepatology|February 22, 2011
To stop or not to stop: the quest for long-term viral suppressionJames Fung, Ching-Lung Lai, Man-Fung Yuen
Digestive Diseases and Sciences|October 30, 2012
The role of steatosis in HBsAg seroclearance for patients with chronic hepatitis B infection: fact or fiction?James Fung, Man-Fung Yuen, Ching-Lung Lai
Expert Opinion on Investigational Drugs|September 24, 2008
LB80380: a promising new drug for the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
Expert Review of Anti-Infective Therapy|June 5, 2010
Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
Journal of Gastroenterology and Hepatology|July 19, 2008
New paradigms for the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
World Journal of Gastroenterology|December 5, 2014
Management of chronic hepatitis B in severe liver diseaseJames Fung, Ching-Lung Lai, Man-Fung Yuen
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Hepatology International|June 18, 2021
The clinical and economic burden of non-alcoholic steatohepatitis in the Middle East: behind the sceneLung-Yi Mak, James Fung
Alimentary Pharmacology & Therapeutics|August 10, 2023
Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation-Insights from a real-world studyLung-Yi Mak, James Fung
Hepatology International|April 19, 2020
Proton pump inhibitors in chronic liver disease: accomplice or bystander?Lung-Yi Mak, James Fung
The Indian Journal of Medical Research|August 21, 2023
World Hepatitis Day 2023: Are we close to the target?Rex Wan-Hin Hui, James Fung
Journal of Gastroenterology and Hepatology|February 22, 2011
To stop or not to stop: the quest for long-term viral suppressionJames Fung, Ching-Lung Lai, Man-Fung Yuen
Digestive Diseases and Sciences|October 30, 2012
The role of steatosis in HBsAg seroclearance for patients with chronic hepatitis B infection: fact or fiction?James Fung, Man-Fung Yuen, Ching-Lung Lai
Expert Opinion on Investigational Drugs|September 24, 2008
LB80380: a promising new drug for the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
Expert Review of Anti-Infective Therapy|June 5, 2010
Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
Journal of Gastroenterology and Hepatology|July 19, 2008
New paradigms for the treatment of chronic hepatitis BJames Fung, Ching-Lung Lai, Man-Fung Yuen
World Journal of Gastroenterology|December 5, 2014
Management of chronic hepatitis B in severe liver diseaseJames Fung, Ching-Lung Lai, Man-Fung Yuen
Pageof 20